Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder

Lucie Bartova, Gernot Fugger, Markus Dold, Alexander Kautzky, Giuseppe Fanelli, Raffaella Zanardi, Diego Albani, Ana Weidenauer, Dan Rujescu, Daniel Souery, Julien Mendlewic, Stuart Montgomery, Joseph Zohar, Chiara Fabbri, Alessandro Serretti, Siegfried Kasper

Research output: Journal article (peer-reviewed) › Journal article

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience